Interaction of A3 adenosine receptor ligands with the human multidrug transporter ABCG2

Megumi Murakami, Dilip K. Tosh, Jinha Yu, Sabrina Lusvarghi, Ryan G. Campbell, Zhan Guo Gao, Kenneth A. Jacobson*, Suresh V. Ambudkar*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Various adenosine receptor nucleoside-like ligands were found to modulate ATP hydrolysis by the multidrug transporter ABCG2. Both ribose-containing and rigidified (N)-methanocarba nucleosides (C2-, N6- and 5′-modified), as well as adenines (C2-, N6-, and deaza modified), were included. 57 compounds out of 63 tested either stimulated (50) or inhibited (7) basal ATPase activity. Structure-activity analysis showed a separation of adenosine receptor and ABCG2 activities. The 7-deaza modification had favorable effects in both (N)-methanocarba nucleosides and adenines. Adenine 37c (MRS7608) and (N)-methanocarba 7-deaza-5′-ethyl ester 60 (MRS7343) were found to be potent stimulators of ABCG2 ATPase activity with EC50 values of 13.2 ± 1.7 and 13.2 ± 2.2 nM, respectively. Both had affinity in the micromolar range for A3 adenosine receptor and lacked the 5′-amide agonist-enabling group (37c was reported as a weak A3 antagonist, Ki 6.82 μM). Compound 60 significantly inhibited ABCG2 substrate transport (IC50 0.44 μM). Docking simulations predicted the interaction of 60 with 21 residues in the drug-binding pocket of ABCG2.

Original languageEnglish
Article number114103
JournalEuropean Journal of Medicinal Chemistry
Volume231
DOIs
StatePublished - 5 Mar 2022
Externally publishedYes

Keywords

  • A adenosine receptor
  • ABC transporter
  • ABCG2
  • ATP hydrolysis
  • Drug transport
  • Multidrug resistance

Fingerprint

Dive into the research topics of 'Interaction of A3 adenosine receptor ligands with the human multidrug transporter ABCG2'. Together they form a unique fingerprint.

Cite this